Amferia kills bacteria

Amferia AB is a Swedish company that develops and markets new medical devices with emphasis on antibacterial products. The core focus of Amferia is to develop materials that can efficiently kill bacteria when used as medical devices, for example within wound care. Amferia is a spin-off from research performed at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Dr. Saba Atefyekta

Antibacterial materials,antibiotic resistance,elastomers,and injectable materials

Amferia kills bacteria operates in the Medical equipment manufacturing industry.

Amferia kills bacteria's revenue is 11m - 100m

Amferia kills bacteria has 11 - 50 employees.